Grindr to acquire PurposeMed to expand PrEP access
Grindr has agreed to acquire PurposeMed, the parent company of Freddie, for $250 million in cash and stock, plus up to $70 million tied to performance targets. The acquisition will integrate Freddie’s telehealth, testing, prescription, pharmacy, and patient-support capabilities into Grindr Health, enabling users to access PrEP assessments, clinical care, prescriptions, refills, and medication delivery. The transaction is expected to close in Q4 2026, subject to customary conditions.
Welldoc launches AI-powered Care Loop for connected chronic care
Welldoc has launched its next-generation AI-Powered Care Loop, connecting patients’ daily health data and experiences with care teams through clinically validated Small Language Models (SLMs) and its AI care agent, Simon. The platform integrates data from sensors and continuous glucose monitors to deliver personalized guidance, identify risks, and generate actionable insights between clinical visits, supporting conditions including obesity, diabetes, and early-stage dementia. Built on more than 500 million health data points and 9.2 million AI-driven engagements, the platform aims to enable continuous, personalized chronic care while maintaining clinician oversight.
QALO launches SL-1 Smart Band for subscription-free health tracking
QALO has launched the SL-1 Smart Band, expanding its wearable portfolio beyond the Smart Ring with a subscription-free device that tracks sleep, activity, stress, HRV, heart rate, SpO2, skin temperature, and women’s health metrics. The HSA/FSA-eligible band offers 12+ days of battery life and connects with the QALO app to maintain a continuous health profile alongside the Smart Ring, with features including the Daily Q Score and menstrual cycle tracking. Priced at $199.95, the Smart Band is available through QALO’s website, with plans to expand into 50 Walmart locations in the US this fall.
